Melobax (Meloxicam)

Meloxicam works by selectively inhibiting the cyclooxygenase‑2 (COX‑2) enzyme, which reduces the production of prostaglandins—chemical mediators that cause inflammation, pain and fever. This selective action aims to provide anti‑inflammatory benefits while sparing COX‑1 activity that protects the stomach lining.

The appropriate dose of Melobax is determined by the prescribing clinician based on the patient’s condition, severity, age and renal function. Dosage may be adjusted during treatment, and patients should follow the prescriber’s instructions without deviation.

Safety of meloxicam in pregnancy and lactation has not been definitively established. It should only be used if the potential benefit justifies the possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity of Melobax. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Melobax (meloxicam) is more COX‑2 selective than many traditional NSAIDs such as ibuprofen or naproxen, which may translate into a lower incidence of gastrointestinal irritation. However, it still carries cardiovascular and renal risks similar to other NSAIDs, so patient selection remains important.

Melobax should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and excessive heat to maintain its stability and potency throughout its shelf life.

Melobax is taken orally, usually as a whole tablet swallowed with a full glass of water. It can be taken with or without food, although taking it with food may reduce occasional stomach discomfort.

Serious adverse events include gastrointestinal ulceration or bleeding, cardiovascular complications such as heart attack or stroke, renal impairment leading to reduced kidney function, severe skin reactions like Stevens‑Johnson syndrome, and significant liver enzyme elevations. Immediate medical attention is required if any of these occur.

Melobax should be avoided in patients with known hypersensitivity to meloxicam or other NSAIDs, active gastrointestinal ulcer or bleeding, severe heart failure, uncontrolled hypertension, and in individuals with significant renal or hepatic impairment unless specifically directed by a physician.